A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group
about
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseTiotropium versus ipratropium bromide for chronic obstructive pulmonary diseaseTiotropium for stable chronic obstructive pulmonary diseasePrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary diseaseTiotropium: an inhaled, long-acting anticholinergic drug for chronic obstructive pulmonary disease.Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchEvaluating the cost-effectiveness of tiotropium versus salmeterol in the treatment of chronic obstructive pulmonary disease.Chronic obstructive pulmonary disease * 12: New treatments for COPDUnderdiagnosed asthma in South Australia.Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease.Pharmacologic treatment of chronic obstructive pulmonary disease: past, present, and future.Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial.Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD.Effects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.Adherence to GOLD guideline treatment recommendations among pulmonologists in TurkeyChronic obstructive pulmonary disease: the evidence for use of tiotropium.The Saudi Initiative for Asthma - 2016 update: Guidelines for the diagnosis and management of asthma in adults and children.Combination inhaled bronchodilator therapy in the management of chronic obstructive pulmonary disease.COPD--the primary care perspective: addressing epidemiology, pathology, diagnosis, treatment of smoking's multiple morbidities and the patient's perspective.Pharmacotherapies for COPD.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Treatment persistence and compliance with medications for chronic obstructive pulmonary diseaseThe combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease.Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease.Efficacy of tiotropium in the prevention of exacerbations of COPD.Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease.The Saudi Guidelines for the Diagnosis and Management of COPD.Tiotropium bromide for chronic obstructive pulmonary disease.Indacaterol: pharmacologic profile, efficacy and safety in the treatment of adults with COPD.NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary disease.Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.Do we know the minimal clinically important difference (MCID) for COPD exacerbations?What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?Once-daily glycopyrronium via the Breezhaler® device for the treatment of COPD: pharmacological and clinical profile.
P2860
Q24187073-5735D513-749E-4515-9F5A-F5AF9F4EB771Q24198068-6C615DB3-E831-4E4E-BA96-53C650519794Q24246991-CA31E321-BF11-4713-9D46-9EB0A57506C9Q27348844-EF7E0DD6-2269-4FF8-80C9-ADF14C393EF0Q33944981-37B494A0-AD66-46D5-842C-7B0DEC0A8DBCQ34177358-33D016E3-329F-4F9B-B0AB-E9A40D90765AQ34944616-3260A625-B281-44B7-A6D1-B8BE2F8AA103Q35205369-7A51C4A3-3E97-42E9-A70D-3C60419160CAQ35208742-FE82FC50-8042-4545-BDCF-958829FFAFEBQ35535482-16576653-2214-4AE4-98D1-DEF676CD73C7Q35535487-E2F56BCD-F851-4854-8DB6-FFD53616EAA8Q35574022-C61A1519-0D3D-4C0C-B76E-85375865AD97Q35695190-27036A5D-0E84-4D4E-85BE-07ABB71E0922Q35766346-9A4FFE9B-17C6-4D7C-BF94-6865A482A3AEQ35766357-C9E790B3-928A-4606-8428-E1493A4CD602Q35841607-1BCAF3B6-06AA-4CF7-900B-F8C2A7BDE725Q36170545-7EB61896-32A2-4A36-914F-EDA1D279F5DEQ36184259-54DE7DEA-F680-4CA8-91CD-C86C89109856Q36196805-F40FDEE8-6A5C-44F9-B1F1-46A3F3B98582Q36200675-7E7B3EEE-4E16-4434-B2B2-5181CD0450DCQ36390663-9BCC68EC-3D59-4CEA-8CE4-757905E1C4CFQ36405313-447EDF2A-8A9D-45B8-85CB-BCD56A4142E0Q36566081-4CBBA6D9-BE81-4F75-852B-811FAFB129A5Q36742419-4624EDA1-A811-4DE9-9B58-D607A36352ABQ36761477-96B78B74-12E4-4E83-9431-74DF22C641DFQ36843717-DCF00FF1-5B8C-4256-B0CE-7DF4F70FD2EBQ37177278-87A2C74C-6109-4F9C-B0AC-1A251A3BD41CQ37212357-BF961173-2116-4B78-AAFA-BF2B5BE159A4Q37221196-CF9EC4F1-5430-4C86-B2CF-F8BE82686B20Q37310689-6858E561-9692-4EDE-B4B2-4D04F4F04A9AQ37555782-F8B069F3-00CB-4CDB-A0C1-1ACA726A83A8Q37667100-439340FA-C629-4ED3-88C0-A250C833F083Q37733309-69081A2C-2D66-486B-89E2-38D5319BD1A3Q37755016-85D143B1-66BD-4A14-9BED-BD9B4BFF9E6CQ37846698-97A69FA9-BDE4-43E6-A57B-277190993CAEQ37867838-ED43AC1B-F949-4A1B-9E17-2510697903BDQ37973132-245266DC-56D3-45CB-8783-8AF3812A5BF9Q38091512-412B2C2D-D115-4F99-9422-22787F44469BQ38095562-47D1C6E1-71D7-43B2-B7BD-3C8FE54E2B94Q38131050-C9654311-DE01-48EA-9209-40855F512494
P2860
A randomised controlled comparison of tiotropium nd ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@ast
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@en
type
label
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@ast
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@en
prefLabel
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@ast
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@en
P2093
P2860
P356
P1433
P1476
A randomised controlled compar ...... e Dutch Tiotropium Study Group
@en
P2093
Cornelissen PJ
Korducki L
van Noord JA
P2860
P304
P356
10.1136/THORAX.55.4.289
P407
P577
2000-04-01T00:00:00Z